B+
Bull case
30%
Probability
Target price
$11.00
+41.2% vs current
AVAH
Aveanna HealthcareCNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-18
AI scenario view
RankAlpha Sentiment CodexMost likely
B
Base case
45%
Probability
Target price
$8.50
+9.1% vs current
B-
Bear case
25%
Probability
Target price
$4.75
-39.0% vs current
AI sentiment snapshot
Latest data as of 2026-05-06
Recent news sentiment (30D)
-30.2
Negative
Company
-
Unavailable
Macro
-30.2
Negative
Pulse
-
Unavailable
Sentiment proxy
+56.0
Score
AI commentary
Recent headline flow is modestly constructive and mostly company-driven: January guidance was raised, March results were strong, and the Family First transaction added a new growth hook. Still, coverage is not deep, the packet has no usable social-context support, and the thesis remains primarily an execution-and-deleveraging monitoring view rather than a fully validated broad-consensus rerating.
RankAlpha Sentiment Codex - 2026-05-06
Open full AI memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-05-14catalystMay 14, 2026 Q1 print is the first check on held FY26 guidanceHigh impact
Aveanna reported Q4 2025 revenue of $662.5 million (+27.4% y/y), Q4 adjusted EBITDA of $85.0 million (+54.0% y/y), and maintained FY2026 guidance for $2.54-$2.56 billion of revenue and $318-$322 million of adjusted EBITDA; the May 14, 2026 earnings call is the next proof point that the March strength is carrying forward. [#8-K-2026-03-20]
2026-06-30eventFamily First Homecare acquisition can add PDS scale if Q2 close stays on trackHigh impact
Aveanna agreed to acquire Family First Homecare, a 27-location multi-state pediatric home care provider, for $175.5 million, with closing expected in Q2 2026. A timely close and early integration progress would reinforce the private-duty nursing growth story, while delays would weaken the near-term M&A contribution case.
2026-12-31catalystFree-cash-flow execution and deleveraging remain the main rerating pathHigh impact
FY2025 free cash flow was $131.0 million, cash was $193.3 million, and the revolver was undrawn, but total indebtedness remained $1.4867 billion at January 3, 2026. If Aveanna sustains cash generation and reduces leverage, the equity can rerate from a depressed base; if deleveraging stalls, leverage remains the central overhang. [#10-K-2026-03-19]
Recommendation
N/A
No formal recommendation provided.
As of 2026-05-06 • Updated nightlySource: Internal modelMethodology